Stereotaxis STXS recently announced the regulatory submissions for the MAGiC catheter, which is seeking marketing clearance in Europe and the United States.These submissions follow successful initial ...
ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Stereotaxis STXS recently announced the publication of initial clinical results from its MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology. The study, titled “First In-Human ...
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it ...
ST. LOUIS, July 11, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark ...
Stereotaxis STXS has announced the first successful U.S. procedures using its MAGiC robotic magnetic ablation catheter, following recent approval from the FDA. The milestone highlights the company’s ...
Stereotaxis STXS has announced the first successful U.S. procedures using its MAGiC robotic magnetic ablation catheter, following recent approval from the FDA. The milestone highlights the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results